PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
13.18%
Revenue growth at 75-90% of TSM's 17.41%. Bill Ackman would push for innovation or market expansion to catch up.
15.77%
Gross profit growth similar to TSM's 15.50%. Walter Schloss would assume both firms track common industry trends.
222.37%
EBIT growth above 1.5x TSM's 16.36%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
222.37%
Operating income growth above 1.5x TSM's 16.36%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
846.15%
Net income growth above 1.5x TSM's 33.45%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
746.15%
EPS growth above 1.5x TSM's 33.21%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
746.15%
Diluted EPS growth above 1.5x TSM's 33.21%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.18%
Share change of 0.18% while TSM is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
1.62%
Diluted share change of 1.62% while TSM is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-0.18%
Dividend reduction while TSM stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
56.44%
OCF growth above 1.5x TSM's 18.50%. David Dodd would confirm a clear edge in underlying cash generation.
71.22%
Positive FCF growth while TSM is negative. John Neff would see a strong competitive edge in net cash generation.
110.53%
10Y revenue/share CAGR under 50% of TSM's 228.97%. Michael Burry would suspect a lasting competitive disadvantage.
64.71%
5Y revenue/share CAGR under 50% of TSM's 144.41%. Michael Burry would suspect a significant competitive gap or product weakness.
24.45%
3Y revenue/share CAGR under 50% of TSM's 60.22%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
185.38%
10Y OCF/share CAGR 1.25-1.5x TSM's 153.95%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
28.02%
Below 50% of TSM's 128.83%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
61.34%
3Y OCF/share CAGR above 1.5x TSM's 31.94%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
254.82%
Net income/share CAGR 1.25-1.5x TSM's 206.39%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
208.77%
5Y net income/share CAGR similar to TSM's 218.15%. Walter Schloss might see both on parallel mid-term trajectories.
35.10%
Below 50% of TSM's 86.23%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
211.42%
10Y equity/share CAGR 1.25-1.5x TSM's 174.31%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
64.12%
5Y equity/share CAGR at 50-75% of TSM's 114.21%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
8.56%
Below 50% of TSM's 59.60%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4.28%
AR growth is negative/stable vs. TSM's 15.72%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-3.63%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
2.79%
Positive asset growth while TSM is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
6.49%
75-90% of TSM's 7.23%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
0.43%
We have some new debt while TSM reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
2.81%
R&D dropping or stable vs. TSM's 10.77%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
2.01%
SG&A declining or stable vs. TSM's 16.58%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.